Catherine Bollard

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Catherine Bollard

Catherine Bollard was last confirmed as Board Member at Cabaletta Bio, Inc. (CABA) in a filing dated April 23, 2024. Cabaletta Bio, Inc. reported in an 8-K filed July 24, 2023 that Catherine Bollard resigned as Chair of the Compensation Committee, effective July 21, 2023.

“(i) Catherine Bollard, M.D. resigned as a member and Chair of the Compensation Committee,”

Cabaletta Bio, Inc. Form 8-K, filed July 24, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Catherine Bollard's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Cabaletta Bio, Inc. (CABA)
Board Member

Proxy statement

2019-01-01–2024-04-23

Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Cabaletta Bio, Inc.

CABA

Board Member

Since 2019-01-01, last confirmed 2024-04-23

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: Chair of the Compensation Committee Cabaletta Bio, Inc. (CABA)
2023-07-21